JPWO2019227085A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019227085A5 JPWO2019227085A5 JP2020565841A JP2020565841A JPWO2019227085A5 JP WO2019227085 A5 JPWO2019227085 A5 JP WO2019227085A5 JP 2020565841 A JP2020565841 A JP 2020565841A JP 2020565841 A JP2020565841 A JP 2020565841A JP WO2019227085 A5 JPWO2019227085 A5 JP WO2019227085A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- combination
- acid
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024060904A JP2024099549A (ja) | 2018-05-24 | 2024-04-04 | 設計された細菌組成物及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862676236P | 2018-05-24 | 2018-05-24 | |
| US62/676,236 | 2018-05-24 | ||
| PCT/US2019/034069 WO2019227085A1 (en) | 2018-05-24 | 2019-05-24 | Designed bacterial compositions and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024060904A Division JP2024099549A (ja) | 2018-05-24 | 2024-04-04 | 設計された細菌組成物及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021524476A JP2021524476A (ja) | 2021-09-13 |
| JPWO2019227085A5 true JPWO2019227085A5 (enrdf_load_stackoverflow) | 2022-06-01 |
Family
ID=68615645
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565841A Pending JP2021524476A (ja) | 2018-05-24 | 2019-05-24 | 設計された細菌組成物及びその使用 |
| JP2024060904A Pending JP2024099549A (ja) | 2018-05-24 | 2024-04-04 | 設計された細菌組成物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024060904A Pending JP2024099549A (ja) | 2018-05-24 | 2024-04-04 | 設計された細菌組成物及びその使用 |
Country Status (10)
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1220326A1 (zh) | 2013-03-15 | 2017-05-05 | Seres Therapeutics, Inc. | 基於网络微生物组成和方法 |
| EP3444330B1 (en) * | 2016-06-14 | 2025-08-20 | HealthBiome, Inc. | Strain of genus agathobaculum having effects of preventing or treating degenerative brain diseases, and use thereof |
| KR102658297B1 (ko) | 2016-06-14 | 2024-04-18 | 베단타 바이오사이언시즈, 인크. | 클로스트리디움 디피실레 감염의 치료 |
| CN111212655A (zh) | 2017-08-14 | 2020-05-29 | 赛里斯治疗公司 | 用于治疗胆汁淤积性疾病的组合物和方法 |
| KR20200079292A (ko) | 2017-10-30 | 2020-07-02 | 세레스 테라퓨틱스, 인코포레이티드 | 항생제 내성을 치료하기 위한 조성물 및 방법 |
| EP3597202A1 (en) * | 2018-07-20 | 2020-01-22 | Maat Pharma | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
| CN112888447A (zh) | 2018-08-17 | 2021-06-01 | 韦丹塔生物科学股份有限公司 | 减少菌群失调和恢复微生物群系的方法 |
| IL317208A (en) | 2019-09-24 | 2025-01-01 | Prolacta Bioscience Inc | Preparations and methods for treating inflammatory and immune diseases |
| CN112578123B (zh) * | 2019-09-27 | 2022-10-25 | 成都中医药大学 | 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途 |
| CN115175575A (zh) * | 2019-11-27 | 2022-10-11 | 赛里斯治疗公司 | 设计的细菌组合物及其用途 |
| AU2020407659A1 (en) * | 2019-12-20 | 2022-07-28 | Icahn School Of Medicine At Mount Sinai | Compositions and methods for treating inflammatory bowel disease |
| IL271775A (en) * | 2019-12-31 | 2021-06-30 | Biomica Ltd | A microbial consortium and its uses |
| WO2021163212A1 (en) | 2020-02-10 | 2021-08-19 | Native Microbials, Inc. | Microbial compositions and methods of use for canine enteropathy and dysbiosis |
| US20230106313A1 (en) * | 2020-02-12 | 2023-04-06 | Universität Zürich | A bacterial composition for the treatment of cancer |
| GB202007452D0 (en) * | 2020-05-19 | 2020-07-01 | Microbiotica Ltd | Threrapeutic bacterial composition |
| US20230233620A1 (en) * | 2020-05-21 | 2023-07-27 | Chan Zuckerberg Biohub, Inc. | High-complexity synthetic gut bacterial communities |
| BR112023002758A2 (pt) | 2020-08-14 | 2023-05-02 | Prolacta Bioscience Inc | Composições de oligossacarídeos de leite humano para uso com bacterioterapias |
| KR102700146B1 (ko) * | 2020-09-28 | 2024-08-28 | 씨제이바이오사이언스 주식회사 | 미생물을 포함하는 염증성 질환 진단 또는 치료용 조성물 |
| WO2022159711A1 (en) * | 2021-01-21 | 2022-07-28 | Vedanta Biosciences, Inc. | Compositions and methods for treating hepatic encephalopathy |
| EP4294415A4 (en) * | 2021-02-17 | 2025-08-13 | Seres Therapeutics Inc | USE OF IMMUNOTHERAPY AND MICROBIOME MODULATION TO TREAT CANCER |
| WO2022236365A1 (en) * | 2021-05-10 | 2022-11-17 | Microba Ip Pty Ltd | Compositions and methods for treating disease |
| CN115806893B (zh) * | 2021-09-13 | 2023-10-20 | 中国科学技术大学 | 普通拟杆菌及其组合物在辅助癌症免疫治疗中的应用 |
| CN114496279B (zh) * | 2022-01-12 | 2022-08-30 | 广州保量医疗科技有限公司 | 菌群移植配型的排序方法、系统、计算机设备及存储介质 |
| CN115852001A (zh) * | 2022-11-23 | 2023-03-28 | 深圳海关动植物检验检疫技术中心 | 一种小麦病原菌检测方法及其应用 |
| GB2627012A (en) * | 2023-02-13 | 2024-08-14 | Acad Medisch Ct | Predictive biomarker of neonatal E.coli mediated sepsis |
| CN117797176B (zh) * | 2024-03-01 | 2024-07-02 | 南京大学 | 双孢梭菌在制备治疗非酒精性脂肪性肝病药物中的应用和一种药物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004104175A2 (en) * | 2003-05-14 | 2004-12-02 | University Of Georgia Research Foundation, Inc. | Probiotic bacteria and methods |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| WO2014088982A1 (en) * | 2012-12-07 | 2014-06-12 | Albert Einstein College Of Medicine Of Yeshiva University | Gut barrier dysfunction treatment and prevention |
| WO2014121302A2 (en) * | 2013-02-04 | 2014-08-07 | Seres Health, Inc. | Compositions and methods |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| CN108348558A (zh) * | 2015-07-08 | 2018-07-31 | 赛里斯治疗公司 | 治疗结肠炎的方法 |
| CN109661236A (zh) * | 2015-11-24 | 2019-04-19 | 赛里斯治疗公司 | 设计的细菌组合物 |
| EP4368254A3 (en) * | 2016-03-14 | 2024-08-14 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
| WO2017160944A2 (en) * | 2016-03-15 | 2017-09-21 | The Regents Of The University Of Michigan | Compositions and methods for treating and preventing graft versus host disease |
| KR20200079292A (ko) * | 2017-10-30 | 2020-07-02 | 세레스 테라퓨틱스, 인코포레이티드 | 항생제 내성을 치료하기 위한 조성물 및 방법 |
| EP3890505A4 (en) * | 2018-12-05 | 2022-11-02 | Seres Therapeutics, Inc. | COMPOSITIONS FOR STABILIZING BACTERIA AND THEIR USES |
-
2019
- 2019-05-24 EP EP19807289.4A patent/EP3801065A4/en active Pending
- 2019-05-24 WO PCT/US2019/034069 patent/WO2019227085A1/en unknown
- 2019-05-24 KR KR1020207036979A patent/KR20210024481A/ko active Pending
- 2019-05-24 CA CA3101184A patent/CA3101184A1/en active Pending
- 2019-05-24 BR BR112020023933-0A patent/BR112020023933A2/pt not_active Application Discontinuation
- 2019-05-24 JP JP2020565841A patent/JP2021524476A/ja active Pending
- 2019-05-24 MX MX2020012602A patent/MX2020012602A/es unknown
- 2019-05-24 AU AU2019275125A patent/AU2019275125A1/en not_active Abandoned
- 2019-05-24 CN CN201980048698.5A patent/CN112512342A/zh active Pending
- 2019-05-24 US US17/058,351 patent/US20210196766A1/en not_active Abandoned
-
2024
- 2024-04-04 JP JP2024060904A patent/JP2024099549A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019227085A5 (enrdf_load_stackoverflow) | ||
| EP1037666B1 (en) | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides | |
| Thompson et al. | History and development of plant sterol and stanol esters for cholesterol-lowering purposes | |
| PAUL et al. | On the mechanism of hypocholesterolemic effects of polyunsaturated lipids | |
| ES2685703T3 (es) | Composiciones enriquecidas en DPA de ácidos grasos omega-3 poliinsaturados en forma de ácido libre | |
| JP2021107433A (ja) | ω３脂肪酸の自己乳化組成物 | |
| Hao et al. | Wild melon seed oil reduces plasma cholesterol and modulates gut microbiota in hypercholesterolemic hamsters | |
| JP2018514534A5 (enrdf_load_stackoverflow) | ||
| EP1211955A1 (en) | A nutritional supplement for lowering serum triglyceride and cholesterol levels | |
| CA2630262A1 (en) | The use of isothiocyanates compounds in treating prostatic diseases and skin cancer | |
| JPH10504016A (ja) | サポニンをできれば他の化合物と組合せて含む炎症及び感染症の治療のための腸溶性配合物 | |
| JP4986321B2 (ja) | 炎症性状態処置のための方法および組成物 | |
| Lee et al. | Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol | |
| JPH05194244A (ja) | 必須脂肪酸を含有する薬剤 | |
| IL294736A (en) | Compositions comprising 15-hepe and methods of using the same | |
| JP5118965B2 (ja) | 植物成分を必要とする治療方法 | |
| Kaur et al. | Will Probiotics Provide the Answer for Therapy of Non-alcoholic Fatty Liver Disease (NAFLD) | |
| EP3866615A1 (en) | Human dietary supplement and method for treating digestive system and immune-related disorders | |
| Ash et al. | Phytosterol stearate esters elicit similar responses on plasma lipids and cholesterol absorption but different responses on fecal neutral sterol excretion and hepatic free cholesterol in male Syrian hamsters | |
| CN105087157A (zh) | 一种低甾醇注射用苏子油的精制工艺及其用途 | |
| JPH09291299A (ja) | 抗アレルギー用油脂組成物および用途 | |
| WO2012133198A1 (ja) | 炎症性疾患用栄養組成物 | |
| JP5837315B2 (ja) | 炎症性疾患用栄養組成物 | |
| JP2002532420A (ja) | 腸管完全性の維持および回復のための方法および組成物 | |
| JPH06507161A (ja) | 脂質吸収不良の治療用経腸医薬製剤の製造のための脂質の使用 |